BIOMIRA INC. ANNOUNCES REGULATORY APPROVAL FOR CLINICAL TRIALS IN GERMANY
BIOMIRA INC. ANNOUNCES REGULATORY APPROVAL
FOR CLINICAL TRIALS IN GERMANY
EDMONTON, Alberta, June 15 /PRNewswire/ -- Biomira Inc. (NASDAQ: BIOMF, Toronto, Montreal, Calgary: BRA) today announced that it has received formal regulatory approval to commence clinical trials of its Tru-Scint(R) cancer in vivo diagnostic products in Germany.
Patient testing will be conducted by oncologists and nuclear medicine specialists at 12 cancer centers and hospitals throughout Germany to determine the safety and efficacy of the products. These investigations will complement Canadian Phase I/II trials which have been on-going at major cancer institutes since mid-1991.
In this diagnostic procedure, Biomira's proprietary monoclonal antibody-based agents are labelled with Technetium-99m, a readily available and relatively inexpensive radioisotope. When injected intravenously, Tru-Scint(R) agents target tumor sites and emit a suitable radiation to pinpoint the size and location of the tumor through visualization on a gamma camera. This technology is called radioimmunoimaging.
Three Biomira products will be tested in Germany: Tru-Scint(R) AD(TM) for detecting breast and ovary adenocarcinomas; Tru-Scint(R) SQ(TM) for squamous cell cancers (lung, cervix, head and neck); and Tru-Scint(R) OV(TM) for ovarian cancer.
Biomira is a public biotechnology firm which has four in vitro test kits on the market under TRUQUANT(R) label for diagnosing gastrointestinal, ovarian, and breast cancers, plus one for measuring the probability of human anti-mouse antibody (HAMA) reaction. Biomira's THERATOPE(R) cancer treatment products are at various phases in the clinical trial process in Canada and the United States. Biomira holds significant interests in H.C.S. Health Care Systems Inc. of Vancouver, and ADI Diagnostics Inc. of Toronto.
/CONTACT: Alex McPherson, president and CEO, or A.A. "Tony" Noujaim, senior VP and COO, Immunoconjugate Division, or Jane Jack, of Biomira, 403-490-2812/
(BIOMF BRA.) CO: Biomira Inc. ST: Alberta IN: MTC SU: KJ -- LA026 -- 0361 06/15/92 17:21 EDT